Nevertheless, there is still a scarcity of research specifically examining the regulatory mechanisms behind the expression of SLC13A5 in human liver tissue and its role in MASLD pathogenesis. The gene discussed is SLC13A5; the disease is metabolic dysfunction-associated steatotic liver disease.